Laurus Labs Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
7,059
- Stock Symbol
-
540222
- Investments
-
15
- Share Price
-
$25.56
- (As of Thursday Closing)
Laurus Labs General Information
Description
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceutical ingredients (API) including intermediates, Generic Finished dosage forms (FDF), and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, and proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. The company generates revenue from the sale of API, Intermediates and Formulations, Contract research services, and others.
Contact Information
Website
www.lauruslabs.comCorporate Office
- Road Number 1, Plot Number 103
- Jubilee Hills
- Hyderabad, Telangana 500033
- India
Corporate Office
- Road Number 1, Plot Number 103
- Jubilee Hills
- Hyderabad, Telangana 500033
- India
Laurus Labs Stock Performance
As of 12-Nov-2026, Laurus Labs’s stock price is $25.56. Its current market cap is $13.8B with 540M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $25.56 | $25.92 | $9.96 - $26.42 | $13.8B | 540M | 96.6K | $0.27 |
Laurus Labs Financials Summary
As of 30-Sep-2026, Laurus Labs has a trailing 12-month revenue of $844M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 11,411,143 | 5,888,848 | 4,183,036 | 2,780,480 |
| Revenue | 843,682 | 760,632 | 651,377 | 604,185 |
| EBITDA | 261,073 | 205,561 | 130,777 | 95,075 |
| Net Income | 144,510 | 100,583 | 42,376 | 19,393 |
| Total Assets | 1,198,702 | 1,114,033 | 1,091,378 | 1,005,717 |
| Total Debt | 273,305 | 266,922 | 323,095 | 309,065 |
Laurus Labs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Laurus Labs Comparisons
Industry
Financing
Details
Laurus Labs Competitors (30)
One of Laurus Labs’s 30 competitors is Torrent Pharmaceuticals, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Corporation | Ahmedabad, India | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Cipla | Corporation | Mumbai, India |
Laurus Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Laurus Labs Patents
Laurus Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023175526-A1 | Process for preparation of azabicyclo [3.1.0] hexane intermediates | Inactive | 16-Mar-2022 | ||
| WO-2023126969-A1 | Oral films of anit-parasitic drugs | Inactive | 30-Dec-2021 | ||
| WO-2023126971-A1 | Oral films of anti-emetic drugs | Inactive | 30-Dec-2021 | ||
| EP-4456873-A1 | Oral films of antipruritic drugs | Inactive | 30-Dec-2021 | ||
| EP-4456873-A4 | Oral films of antipruritic drugs | Inactive | 30-Dec-2021 | A61K9/7007 |
Laurus Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Laurus Labs Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Laurus Labs Investments & Acquisitions (15)
Laurus Labs’s most recent deal was a Merger/Acquisition with Galenvs Sciences for . The deal was made on 29-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Galenvs Sciences | 29-Oct-2026 | Merger/Acquisition | Biotechnology | ||
| Aarvik Therapeutics | 29-Sep-2025 | Early Stage VC | Drug Discovery | ||
| Kurnool Renewables | 28-Mar-2025 | Secondary Transaction - Private | Energy Production | ||
| Laurus Bio | 06-Dec-2024 | Later Stage VC | Other Pharmaceuticals and Biotechnology | ||
| Krka Pharma | 14-Apr-2024 | Joint Venture | Pharmaceuticals |
Laurus Labs ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
33.67 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Laurus Labs Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SI & C Resins | Hyderabad, India | 2022 | |
| Laurus Bio | Bangalore, India | 2005 |
Laurus Labs FAQs
-
When was Laurus Labs founded?
Laurus Labs was founded in 2005.
-
Where is Laurus Labs headquartered?
Laurus Labs is headquartered in Hyderabad, India.
-
What is the size of Laurus Labs?
Laurus Labs has 7,059 total employees.
-
What industry is Laurus Labs in?
Laurus Labs’s primary industry is Pharmaceuticals.
-
Is Laurus Labs a private or public company?
Laurus Labs is a Public company.
-
What is Laurus Labs’s stock symbol?
The ticker symbol for Laurus Labs is 540222.
-
What is the current stock price of Laurus Labs?
As of 12-Nov-2026 the stock price of Laurus Labs is $25.56.
-
What is the current market cap of Laurus Labs?
The current market capitalization of Laurus Labs is $13.8B.
-
What is Laurus Labs’s current revenue?
The trailing twelve month revenue for Laurus Labs is $844M.
-
Who are Laurus Labs’s competitors?
Torrent Pharmaceuticals, Zydus Lifesciences, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, and Cipla are some of the 30 competitors of Laurus Labs.
-
What is Laurus Labs’s annual earnings per share (EPS)?
Laurus Labs’s EPS for 12 months was $0.27.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
